Louise Cadzow

Louise Cadzow

Company: KSQ Therapeutics

Job title: Senior Director, Head of In Vivo Pharmacology


Harnessing Genome-scale In Vivo T-Cell CRISPR Screen to Identify Novel Immuno-Oncology Targets For the Treatment of Solid Tumors 2:35 pm

• Developed a novel CRISPRomics® platform that enabled in vivo genome-wide CRISPR/Cas9 screens in primary T-cells • Systematic identification and validation of targets that can significantly improve T-cell function in solid tumor setting • Developed CRISPR2 technology that enables the identification of optimal T-cell target combinations that drive anti-tumor responseRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.